Global diabetes spending by market 2013-2018

This statistic shows the global spending on diabetes in developed and so called pharmerging markets from 2013 to 2018. In 2013, the developed diabetes market expended 35 billion U.S. dollars. Among others, growth in spending is driven by the increasing price of modern insulin in the United States. In developed markets, new therapies targeting diabetes is a significant driver of market growth.

Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*

Characteristic	Developed markets	Pharmerging markets
-	-	-
-	-	-
-	-	-
-	-	-
-	-	-
-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

November 2014

More information

Region

Worldwide

Survey time period

2013 and 2014

Supplementary notes

* Developed: U.S., Japan, Germany, France, Italy, Spain, U.K., Canada, South Korea. Pharmerging: China, Brazil, Russia, India, Algeria, Argentina, Colombia, Egypt, Indonesia, Mexico, Nigeria, Pakistan, Poland, Romania, Saudi Arabia, South Africa, Thailand, Turkey, Ukraine, Venezuela, Vietnam. Class forecasts adapted from IMS Market Prognosis September 2014. Spending in US$ with variable exchange rates. Growth in US$ at constant exchange rates.

Open this statistic in...

Spanish

Citation formats